Acquired Rifampicin Resistance in Thrice-Weekly Antituberculosis Therapy: Impact of HIV and Antiretroviral Therapy

Initial Drug Resistance and Tuberculosis Treatment Outcomes: Systematic Review and Meta-analysis

(2013) Woojin Lew et al.   ANNALS OF INTERNAL MEDICINE

Efficacy and safety of thrice weekly DOTS in tuberculosis patients with and without HIV co-infection: an observational study

(2013) Richa Vashishtha et al.   BMC INFECTIOUS DISEASES

Antituberculosis Drug Resistance Acquired During Treatment: An Analysis of Cases Reported in California, 1994–2006

(2012) Travis C. Porco et al.   CLINICAL INFECTIOUS DISEASES

An Updated Systematic Review and Meta-analysis on the Treatment of Active Tuberculosis in Patients With HIV Infection

(2012) F. Ahmad Khan et al.   CLINICAL INFECTIOUS DISEASES

Efficacy and Safety of Once-Daily Nevirapine- or Efavirenz-Based Antiretroviral Therapy in HIV-Associated Tuberculosis: A Randomized Clinical Trial

(2011) S. Swaminathan et al.   CLINICAL INFECTIOUS DISEASES

Integration of Antiretroviral Therapy with Tuberculosis Treatment

(2011) Salim S. Abdool Karim et al.   NEW ENGLAND JOURNAL OF MEDICINE

Treatment of Active Tuberculosis in HIV‐Coinfected Patients: A Systematic Review and Meta‐Analysis

(2010) Faiz A. Khan et al.   CLINICAL INFECTIOUS DISEASES

Impact of HIV Infection on the Recurrence of Tuberculosis in South India

(2010) Sujatha Narayanan et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy of a 6-month versus 9-month Intermittent Treatment Regimen in HIV-infected Patients with Tuberculosis

(2009) Soumya Swaminathan et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Effect of Duration and Intermittency of Rifampin on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis

(2009) Dick Menzies et al.   PLOS MEDICINE